Document is current
Any future updates will be listed below
-
Authors
Ramani, Biswarathan https://orcid.org/0000-0002-9723-5599
Rose, Indigo V. L. https://orcid.org/0000-0003-0491-1269
Teyssier, Noam
Pan, Andrew
Danner-Bocks, Spencer https://orcid.org/0009-0009-1435-7354
Sanghal, Tanya
Yadanar, Lin
Tian, Ruilin https://orcid.org/0000-0001-7680-6682
Ma, Keran
Palop, Jorge J. https://orcid.org/0000-0001-6086-1070
Kampmann, Martin https://orcid.org/0000-0002-3819-7019
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01 AG082141, K99 AG062776, RF1 AG062234)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R25 NS070680, K08 NS133300, T32 NS115706)
California Institute for Regenerative Medicine (EDUC4-12812)
Larry L. Hillblom Foundation (UCSF Hillblom/BARI Graduate Fellowship Award)
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 1 July 2025
First Online: 22 August 2025
Competing interests
: B.R., I.V.L.R., A.P. and M.K. have filed a patent application on in vivo screening methods. M.K. is an inventor on US Patent 11,254,933 related to CRISPRi and CRISPRa screening, a coscientific founder of Montara Therapeutics and serves on the Scientific Advisory Boards of Engine Biosciences, Alector and Montara Therapeutics, and is an advisor to Modulo Bio and Recursion Therapeutics.
